Nucleobindin 2 in human breast carcinoma as a potent prognostic factor

Shiho Suzuki, Kiyoshi Takagi, Yasuhiro Miki, Yoshiaki Onodera, Jun Ichi Akahira, Akiko Ebata, Takanori Ishida, Mika Watanabe, Hironobu Sasano, Takashi Suzuki

研究成果: Article査読

43 被引用数 (Scopus)


It is well-known that estrogens immensely contribute to the progression of human breast carcinoma, but their detailed molecular mechanisms remain largely unclear. In this study, we identified nucleobindin 2 (NUCB2) as a gene associated with recurrence based on microarray data of estrogen receptor (ER)-positive breast carcinoma cases (n=10), and subsequent in vitro study showed that NUCB2 expression was upregulated by estradiol in ER-positive MCF-7 cells. However, NUCB2 has not yet been examined in breast carcinoma, and its significance remains unknown. Therefore, we further examined the biological functions of NUCB2 in breast carcinoma using immunohistochemistry and in vitro studies. NUCB2 immunoreactivity was detected in carcinoma cells in 77 of 161 (48%) breast cancer cases, and positively associated with lymph node metastasis and ER status of the patients. In addition, NUCB2 status was significantly associated with an increased risk of recurrence and adverse clinical outcome of the patients using both univariate and multivariate analyses. Results of siRNA transfection experiments showed that NUCB2 significantly increased cell proliferation, and migration and invasion properties in both MCF-7 and ER-negative SK-BR-3 cells. These results suggest that NUCB2 is upregulated by estrogens and plays an important role, especially in the process of metastasis, in breast carcinomas. NUCB2 status is considered a potent prognostic factor in human breast cancer.

ジャーナルCancer science
出版ステータスPublished - 2012 1

ASJC Scopus subject areas

  • 腫瘍学
  • 癌研究


「Nucleobindin 2 in human breast carcinoma as a potent prognostic factor」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。